Mark Sullivan
General Counsel at Definium Therapeutics, Inc. (DFTX); General Counsel at Mind Medicine (MindMed) Inc. (DFTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 29SEC | DFTXDefinium Therapeutics, Inc. | Sell Plan | 14,051494,228 held (−3%) | $36.57 | $514K | -12.2% |
| Jun 26SEC | DFTXDefinium Therapeutics, Inc. | Sell Plan | 13,008320,571 held (−4%) | $45.03 | $586K | -28.7% |
| Mar 26SEC | DFTXDefinium Therapeutics, Inc. | Sell Plan | 10,702271,079 held (−4%) | $18.47 | $198K | +73.8% |
| Dec 29SEC | DFTXMind Medicine (MindMed) Inc. | Sell Plan | 11,276282,576 held (−4%) | $13.15 | $148K | +144.1% |
- Sell
General Counsel Mark Sullivan sold $514K of DFTX at $36.57 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Mark Sullivan sold $586K of DFTX at $45.03 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Mark Sullivan sold $198K of DFTX at $18.47 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Mark Sullivan sold $148K of DFTX at $13.15 — pre-scheduled 10b5-1 plan sale.